The disparity in access to new medication by type of health insurance: Lessons from Germany

Medical Care

Volumn 42, Issue 5, 2004, Pages 487-491

  Krobot, Karl J ^a,d   Miller, William C ^a,c   Kaufman, Jay S ^a   Christensen, Dale B ^b   Preisser, John S ^a   Ibrahim, Michel A ^a  

^a IL   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d NONE   (Germany)

Author keywords

Access to care; Germany; Health insurance; Migraine

Indexed keywords

SEROTONIN AGONIST; SUMATRIPTAN;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL PRACTICE; ECONOMICS; FEMALE; GERMANY; HEALTH CARE DELIVERY; HEALTH INSURANCE; HEALTH SERVICES RESEARCH; HUMAN; MALE; MIDDLE AGED; MIGRAINE; PRESCRIPTION; PRIMARY HEALTH CARE; RETROSPECTIVE STUDY; STATISTICS;

ADOLESCENT; ADULT; AGED; FEMALE; GERMANY; HEALTH SERVICES ACCESSIBILITY; HEALTH SERVICES RESEARCH; HUMANS; INSURANCE, HEALTH; MALE; MIDDLE AGED; MIGRAINE DISORDERS; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTIONS, DRUG; PRIMARY HEALTH CARE; RETROSPECTIVE STUDIES; SEROTONIN AGONISTS; SUMATRIPTAN;

EID: 2542421998     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mlr.0000124265.13559.02     Document Type: Article

References (21)

1. US Congress Office of Technology Assessment. Docs Health Insurance Make a Difference? Background Paper; OTA-BP-H-99 Washington, DC: US Government Printing Office; 1992.
2. Soumerai SB, McLaughlin TJ, Ross-Degnan D, et al. Effects of a limit on Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia. N Engl J Med. 1994;331:650-655.
3. Sclar DA, Robison LM, Skaer TL, et al. What factors influence the prescribing of antidepressant pharmacotherapy? An assessment of national office-based encounters. Int J Psychiatry Med. 1998;28:407-419.
4. Wenneker MB, Weissman JS, Epstein AM. The association of payer with utilization of cardiac procedures in Massachusetts. JAMA. 1990;264:1255-1260.
5. Sorlie PD, Johnson NJ, Backlund E, et al. Mortality in the uninsured compared with that in persons with public and private health insurance. Arch Intern A fed. 1994;154:2409-2416.
6. Franks P, Clancy CM, Gold MR. Health insurance and mortality. Evidence from a national cohort. JAMA. I993;270:737-741.
7. Wilkinson M, Pfaffenrath V, Schoenen J, et al. Migraine and cluster headache - their management with sumatriptan: a critical review of the current clinical experience. Cephalalgia. 1995;15:337-357.
8. Diener HC, Brune K, Gerber W-D, et al. Behandlung der Migräneattacke und Migräneprophylaxe. Dt Ärztebl. 1997;94:A-3092-3102.
9. Diener HC, Brune K, Gerber WD, et al. [Treatment of migraine attacks and migraine prophylaxis: recommendations of the German Migraine and Headache Society]. Med Monatsschr Pharm. 1998;21:30-39.
10. Robbins AS, Chao SY, Fonseca VP. What's the relative risk? A method to directly estimate risk ratios in cohort studies of common outcomes. Ann Epidemiol. 2002;12:452-454.
11. Wacholder S. Binomial regression in GLIM: estimating risk ratios and risk differences. Am J Epidemiol. 1986;123:174-184.
12. McNutt LA, Wu C, Xue X, Hafner JP. Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol. 2003;157:940-943.
13. Liang K-Y, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13-22.
14. White H. Maximum likelihood estimation of misspecified models. Econometrica. 1982;50:1-25.
15. Stata Statistical Software [computer program], version 7. College Station, TX: Stata Corp; 2001.
16. Lurie N, Ward NB, Shapiro MF, et al. Termination from Medi-Cal-does it affect health? W Engl J Med. 1984;311:480-484.
17. Lurie N, Ward NB, Shapiro MF, et al. Termination of Medi-Cal benefits. A follow-up study one year later. N Engl J Med. 1986;314:1266-1268.
18. Soumerai SB, Ross-Degnan D, Fortess EE, et al. A critical analysis of studies of state drug reimbursement policies: research in need of discipline. Milbank Q. 1993;71:217-252.
19. Manning WG, Newhouse JP, Duan N, et al. Health insurance and the demand for medical care: evidence from a randomized experiment. Am Econ Rev. 1987;77:251-277.
20. Hoopmann M, Schwartz FW, Weber J. Effects of the German 1993 health reform law upon primary care practitioners' individual performance: results from an empirical study in sentinel practices. J Epidemiol Community Health. 1995;49(suppl 1):33-36.
21. Gaist D, Andersen M, Aarup AL, Hallas J, Gram LF. Use of sumatriptan in Denmark in 1994-5: an epidemiological analysis of nationwide prescription data. Br J Clin Pharmacol. 1997;43:429-433.